Peptide BPC-157 + TB-5 (10mg)

Dual-action peptide system — crafted for precision research and reproducibility.

• Contains equal proportions of BPC-157 (5mg) and TB-500 (5mg) for a combined 10 mg total.
• Formulated for controlled investigations of angiogenesis, actin regulation, and cell migration models.
• Independently verified by Vanguard Laboratory for purity and identity assurance.

BPC-157 is a 15-amino-acid peptide isolated from gastric proteins and studied for its potential roles in endothelial stability and angiogenic signaling through VEGFR2 / Akt / eNOS pathways

TB-500 (Thymosin-β4 analog) is a 43-amino-acid actin-binding peptide investigated for cell migration, angiogenesis, and tissue remodeling in both dermal and cardiac models

Combined use of these peptides has been researched for potential synergistic effects on vascular regeneration and soft-tissue repair

Regulatory Status: BPC-157 and TB-500 are not FDA-approved for human or veterinary use and are supplied strictly for research applications.